Dice Stock Analysis

DICE Stock  USD 32.56  0.00  0.00%   
The modest gains experienced by current holders of Dice Molecules could raise concerns from shareholders as the firm is trading at a share price of 32.56 on 21,548 in volume. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in April. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.72. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Dice Molecules partners.
Check out Investing Opportunities to better understand how to build diversified portfolios.
The main objective of Dice Molecules stock analysis is to determine its intrinsic value, which is an estimate of what Dice Molecules Holdings is worth, separate from its market price. There are two main types of Dice Molecules' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Dice Molecules' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Dice Molecules' stock to identify patterns and trends that may indicate its future price movements.
The Dice Molecules stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Dice Molecules is usually not traded on Christmas Day, Thanksgiving Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ). Dice Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Dice Molecules' ongoing operational relationships across important fundamental and technical indicators.

Dice Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.84. Dice Molecules Holdings recorded a loss per share of 2.11. The entity had not issued any dividends in recent years. DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Dice Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To learn more about Dice Molecules Holdings call Kevin Judice at 650 566 1402 or check out https://www.dicemolecules.com.

Dice Molecules Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Dice Molecules' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Dice Molecules Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Dice Molecules had very high historical volatility over the last 90 days
Dice Molecules has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (83.89 M) with loss before overhead, payroll, taxes, and interest of (56.08 M).
Dice Molecules Holdings currently holds about 282.22 M in cash with (64.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.39.
Dice Molecules has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: DICE Therapeutics Now Covered by Canaccord Genuity Group

Dice Molecules Holdings Upcoming and Recent Events

Earnings reports are used by Dice Molecules to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dice Molecules previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
10th of August 2023
Upcoming Quarterly Report
8th of November 2023
Next Financial Report
30th of June 2023
Next Fiscal Quarter End
20th of March 2024
Next Fiscal Year End
31st of March 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Dice Largest EPS Surprises

Earnings surprises can significantly impact Dice Molecules' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates
View All Earnings Estimates

Dice Molecules SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Dice Molecules prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Dice Molecules investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Dice Molecules Holdings specific information freely available to individual and institutional investors to make a timely investment decision.
11th of May 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
29th of March 2023
Unclassified Corporate Event
15th of March 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
14th of February 2023
Unclassified Corporate Event
13th of February 2023
Unclassified Corporate Event
10th of February 2023
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
9th of February 2023
Unclassified Corporate Event
17th of November 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year

Dice Molecules Thematic Classifications

In addition to having Dice Molecules stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Dice Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Dice Molecules is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dice Molecules Holdings backward and forwards among themselves. Dice Molecules' institutional investor refers to the entity that pools money to purchase Dice Molecules' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Ra Capital Management Lp2023-03-31Common Shares7.9 M225.1 M
Fmr Llc2023-03-31Common Shares5.7 M162.7 M
Avoro Capital Advisors Llc2023-03-31Common SharesM113.2 M
Northpond Ventures Llc2023-03-31Common Shares3.3 M94.3 M
Price T Rowe Associates Inc2023-03-31Common Shares3.3 M93.3 M
Blackrock Inc2023-03-31Common SharesM86.3 M
Sands Capital Ventures Llc2023-03-31Common Shares2.7 M78.8 M
Driehaus Capital Management Llc2023-03-31Common SharesM57.3 M
Vanguard Group Inc2023-03-31Common Shares1.9 M55.2 M
Deep Track Capital Lp2023-03-31Common Shares1.6 M45.8 M
Armistice Capital Llc2023-03-31Common Shares1.4 M39.4 M
Note, although Dice Molecules' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Dice Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dice Molecules's market, we take the total number of its shares issued and multiply it by Dice Molecules's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Dice Profitablity

Dice Molecules' profitability indicators refer to fundamental financial ratios that showcase Dice Molecules' ability to generate income relative to its revenue or operating costs. If, let's say, Dice Molecules is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Dice Molecules' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Dice Molecules' profitability requires more research than a typical breakdown of Dice Molecules' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(0.22) (0.24) 
Return on Average Equity(0.24) (0.25) 
Return on Invested Capital(0.36) (0.39) 
Return on Sales(39.03) (40.06) 

Management Efficiency

Dice Molecules Holdings has return on total asset (ROA) of (0.1402) % which means that it has lost $0.1402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.216) %, meaning that it created substantial loss on money invested by shareholders. Dice Molecules' management efficiency ratios could be used to measure how well Dice Molecules manages its routine affairs as well as how well it operates its assets and liabilities. As of May 30, 2023, Return on Average Assets is expected to decline to -0.24. In addition to that, Return on Average Equity is expected to decline to -0.25. Dice Molecules Current Assets are projected to increase significantly based on the last few years of reporting. The past year's Current Assets were at 577.76 Million. The current year's Assets Non Current is expected to grow to about 17.5 M, whereas Return on Average Assets are forecasted to decline to (0.24) .
Last ReportedProjected for 2023
Book Value per Share 14.39  15.53 
Enterprise Value over EBIT(17.00) (18.34) 
Enterprise Value over EBITDA(17.98) (19.40) 
Price to Book Value 2.62  2.59 
Tangible Assets Book Value per Share 15.07  18.53 
Enterprise Value1.5 B1.4 B
Tangible Asset Value594 M640.9 M
The analysis of Dice Molecules' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Dice Molecules' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Dice Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Non Current Liabilities Total
11.8 M
Short Long Term Debt Total
13.3 M
Interest Expense
679 K
Total Operating Expenses
88.2 M
Common Stock Total Equity

Technical Drivers

As of the 30th of May, Dice Molecules shows the Mean Deviation of 2.74, semi deviation of 3.34, and Downside Deviation of 3.52. Dice Molecules Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Dice Molecules Holdings, which can be compared to its rivals. Please confirm Dice Molecules Holdings variance, maximum drawdown, and the relationship between the coefficient of variation and jensen alpha to decide if Dice Molecules Holdings is priced favorably, providing market reflects its regular price of 32.56 per share. Given that Dice Molecules has jensen alpha of 0.2639, we urge you to verify Dice Molecules Holdings's prevailing market performance to make sure the company can sustain itself at a future point.

Dice Molecules Holdings Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Mid-point over period is an average of Dice Molecules Holdings highest and lowest values attained during the given period.

Dice Molecules Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dice Molecules insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dice Molecules' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dice Molecules insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Dice Molecules Predictive Daily Indicators

Dice Molecules intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dice Molecules stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Dice Molecules Forecast Models

Dice Molecules' time-series forecasting models are one of many Dice Molecules' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dice Molecules' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Dice Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dice Molecules prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dice shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Dice Molecules. By using and applying Dice Stock analysis, traders can create a robust methodology for identifying Dice entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(38.50) (39.51) 
Gross Margin 0.90  0.89 
Profit Margin(39.17) (40.20) 

Current Dice Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dice analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dice analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Dice Molecules Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Dice analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dice stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dice Molecules Holdings, talking to its executives and customers, or listening to Dice conference calls.
Dice Analyst Advice Details

Dice Stock Analysis Indicators

Dice Molecules Holdings stock analysis indicators help investors evaluate how Dice Molecules stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dice Molecules shares will generate the highest return on investment. By understating and applying Dice Molecules stock analysis, traders can identify Dice Molecules position entry and exit signals to maximize returns.
Begin Period Cash Flow116.2 M
Common Stock Shares Outstanding39.4 M
Total Stockholder Equity-187.6 M
Total Cashflows From Investing Activities87.5 M
Property Plant And Equipment Net16 M
Cash And Short Term Investments574.2 M
Cash461.4 M
Accounts Payable3.1 M
Net Debt-448.1 M
50 Day M A31.4613
Total Current Liabilities15.1 M
Other Operating Expenses88.2 M
Non Current Assets Total16.2 M
Common Stock Total Equity5000.00
Non Currrent Assets Other198 K
Stock Based Compensation12.8 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Note that the Dice Molecules Holdings information on this page should be used as a complementary analysis to other Dice Molecules' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Dice Stock analysis

When running Dice Molecules' price analysis, check to measure Dice Molecules' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dice Molecules is operating at the current time. Most of Dice Molecules' value examination focuses on studying past and present price action to predict the probability of Dice Molecules' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dice Molecules' price. Additionally, you may evaluate how the addition of Dice Molecules to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Dice Molecules' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dice Molecules. If investors know Dice will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dice Molecules listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Dice Molecules Holdings is measured differently than its book value, which is the value of Dice that is recorded on the company's balance sheet. Investors also form their own opinion of Dice Molecules' value that differs from its market value or its book value, called intrinsic value, which is Dice Molecules' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dice Molecules' market value can be influenced by many factors that don't directly affect Dice Molecules' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dice Molecules' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dice Molecules is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dice Molecules' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Investing Opportunities to better understand how to build diversified portfolios.